The BVA-100 (Blood Volume Analyzer) is a revolutionary instrument, developed by DAXOR Corporation and cleared by the FDA, to precisely measure blood volume in the human body.

Read More

Key Features

  • Superior  blood volume measurement
  • Results in under 1 hour
  • Clinically proven — used in leading hospitals

Latest News

Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for Improved Accuracy of Blood Volume Measurement

Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body.  Albumin is the major carrier molecule in the human body for […]

Read More

University of Hawaii and The Queens’s Hospital Reports on a Study on Critically Ill Patients Utilizing Blood Volume Measurement and Pulmonary Artery Catheterization

New York, NY March 9, 2016 – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announces a study on critically ill patients utilizing blood volume measurement and pulmonary artery catheterization (PAC). Pulmonary artery catheterization, an invasive procedure, involves threading a catheter into the heart to measure pressures. Millions of […]

Read More

Daxor Corporation Announces Upcoming Filing of Form N-CSR for December 31, 2015 and Recent Developments

NEW YORK, NY–(Marketwired – Feb 29, 2016) – Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, expects to be filing a Form N-CSR within the next week disclosing its schedule of portfolio holdings as of December 31, 2015. Copies of the form will be mailed to the Company’s shareholders and will be […]

Read More